类固醇受体辅活化因子-1,steroid receptor coactivator-1
1)steroid receptor coactivator-1类固醇受体辅活化因子-1
2)Steroid receptor coactivator类固醇受体辅活化因子
1.Results Steroid receptor coactivators are essential for several kinds of steroid hormones binding to steroid receptors, so they are important accessory factors that induce the initiation, development and recurrence of breast cance.目的探讨类固醇受体辅活化因子家族在乳腺癌发生、发展、治疗、预后等方面的作用。
3)steroid receptor coactivators类固醇受体辅活化子
1.Changes of expression of steroid receptor coactivators in the burned mice;烧伤后小鼠类固醇受体辅活化子的表达变化
英文短句/例句

1.The Study on the Role of Steroid Receptor Coactivator-3 in Inflammatory/immune Response;类固醇受体辅活化子-3在炎症/免疫反应中的作用
2.Breeding and identification of SRC-3 knock-out mice类固醇受体辅活化子-3基因敲除小鼠的繁殖与鉴定
3.The Study of the Role and Mechanism of Steroid Receptor Coactivator-1 and -3 in Modulation of Stress after Burn Injury;类固醇受体辅活化子SRC-1和SRC-3在烧伤小鼠应激调控中的作用与机制研究
4.Role of Steroid Receptor Coactivator 3 in Escherichia Coli Peritonitis of Mice and Anti-inflammatory Drug Screening类固醇激素受体辅激活子3(SRC-3)在小鼠腹膜炎中的作用及抗炎药物的筛选
5.The Importance of Steroid Receptor Coactivator-3 (SRC-3) on the Treatment of Malignant Hematological Diseases by Natural Drugs类固醇激素受体共活化因子3(SRC-3)在天然药物治疗恶性血液病中的意义
6.PNRC:a new member of nuclear receptor coactivator family核受体辅活化子的家族新成员——PNRC
7.Using enzyme immunoassay method to study the LDL receptor activity of lymphocyte in hypercholesterolemia以免疫酶标法研究实验性高胆固醇血症时淋巴细胞低密度脂蛋白受体活性变化
8.A STUDY ON SEX STEROIDS OF MALE ATLANTIC SALMON SALMO SALAR IN VIVO AND IN VITRO大西洋鲑雄鱼活体和离体分泌性类固醇激素的研究
9.Resolution of(±)-menthol in ionic liquid catalyzed by immobilized lipase on magnetic microspheres离子液体中固定化脂肪酶催化拆分(±)-薄荷醇
10.Correlation of NOR and Steroid Hormone Receptors(SR )With Clinical and Pathological Teatures of Human Breast Cancer乳腺癌核仁组成区和类固醇激素受体与临床病理关系的研究
11.The relation between liver low density lipoprotein (LDL) receptor activity and serum cholesterol levels in human fetus人胚肝低密度脂蛋白受体活性与血清胆固醇水平的关系
12.He's being treated with steroids for leukaemia.他因患白血病正在接受类固醇治疗.
13.Changes of cholesterol 7alpha-hydroxylase,farnesoid X receptor,and small heterodimer partner expression in liver tissues of rats with obstructive cholestasis阻塞性胆汁淤积大鼠肝脏胆固醇7α-羟化酶和核受体FXR、SHP表达变化
14.Expressions of liver X receptor,11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor in the liver of streptozotocin-induced diabetes rat糖尿病大鼠肝X受体、11β-羟基类固醇脱氢酶和糖皮质激素受体表达的改变
15.Activation of Farnesoid X Receptor Down-regulates Expression of Apolipoprotein M in Cultured HepG2 Cell激活类法尼醇X核内受体(FXR)可下调载脂蛋白M在HepG2细胞中的表达
16.The Expression of Scavenger Receptor Class B TypeⅠ in Patients with Hypercholesterolemia高胆固醇血症患者血小板B族Ⅰ型清道夫受体表达的变化
17.The brain produces its own supply of these so-called neurosteroids from either progesterone or cholesterol.脑以黄体激素或类固醇,制造所谓的「神经类固醇」供自家使用。
18.On the Immobilization of Magnetic Polyethylene Glycol with Vitamin B_6;磁性聚乙二醇微球固定化辅酶维生素B_6的研究
相关短句/例句

Steroid receptor coactivator类固醇受体辅活化因子
1.Results Steroid receptor coactivators are essential for several kinds of steroid hormones binding to steroid receptors, so they are important accessory factors that induce the initiation, development and recurrence of breast cance.目的探讨类固醇受体辅活化因子家族在乳腺癌发生、发展、治疗、预后等方面的作用。
3)steroid receptor coactivators类固醇受体辅活化子
1.Changes of expression of steroid receptor coactivators in the burned mice;烧伤后小鼠类固醇受体辅活化子的表达变化
4)steroid receptor coactivator-3类固醇受体辅活化子-3
5)Peroxisome Proliferator-Activated Receptor-γ Coactivator-1过氧化体增殖物激活型受体γ辅激活因子1
1.Effect of Exercise on Peroxisome Proliferator-Activated Receptor-γ Coactivator-1 Expression in Rat Skeletal Muscle;运动对高脂血症大鼠骨骼肌过氧化体增殖物激活型受体γ辅激活因子1表达的影响
6)peroxisome proliferator activated receptor γ coactivator-1过氧化物增殖物激活受体γ辅激活因子1
延伸阅读

正常人白细胞转移因子 , 白细胞转移因子,转移因子药物名称:转移因子英文名:Transfer Factor别名: 正常人白细胞转移因子 , 白细胞转移因子,转移因子外文名:Transfer Factor ,TF适应症: 为细胞免疫反应增强剂,能将细胞免疫活性转移给受体,以提高受体的免疫功能。临床上用于治疗某些抗生素难以控制的病毒性或酶菌性细胞内感染(如带状皰疹、流行性乙型脑炎、白色念珠菌感染等)。对恶性肿瘤可作为辅助治疗剂,对自体免疫性疾病也有一定治疗作用。 用量用法: 一般采用皮下注射,注于上臂内侧或大腿内侧腹股沟下端,1次注射1支,每周1~2次,1个月后改为每2周1次。对带状疱疹,一般只需注射1次。 规格: 注射液:每支2ml,相当于1×1000000000白细胞提取物(上海产),北京产则相当于5~10×1000000000. 注:严禁静脉给药.类别:免疫调节剂